Dr. Wall's lab is developing novel approaches in systems biology to decipher the molecular pathology of autism spectrum disorder and related neurological disorders.

The lab is interested in the design and application of translational bioinformatics tools to help bring whole-genomic data to the point of clinical care. Their current areas of focus are in breast cancer, melanoma, lung and prostate cancer. They are developing new techniques for the analysis of whole-genomic data, including fully sequenced tumor genomes and companion whole-genomic transcriptional assays, so that these data can be rapidly transformed into clinically actionable reports that yield prognostic predictions, drive decision support for alternative lines of therapy, and other medically actionable outcomes.